2096 fundamentals
An in-depth look to SIMCERE PHARMACEUTICAL GRP LTD operating, investing, and financing activities
2096 free cash flow for H2 23 is 46.5 M HKD. For 2023, 2096 free cash flow was -47.33 M HKD and operating cash flow was 486.58 M HKD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM